Rosenau, France

Celine Decaudin

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Celine Decaudin: Innovator in Oncology Drug Formulations

Introduction

Celine Decaudin is a prominent inventor based in Rosenau, France. She has made significant contributions to the field of oncology through her innovative formulations. With a total of 2 patents, her work focuses on improving drug delivery methods for cancer treatment.

Latest Patents

Celine Decaudin's latest patents include an oral formulation and suspension of an oncology drug, as well as dry powder formulations for inhalation. These formulations consist of a uniform blend of two spray-dried powders. The first powder contains spray-dried particles of a therapeutically active ingredient dispersed in a pharmaceutically acceptable hydrophobic excipient. The second powder is formed from a hydrophobic excipient but is substantially free of any therapeutically active ingredient. The active ingredient in the first powder is loaded sufficiently high to compensate for the absence of active ingredients in the second powder. A detailed process for preparing such formulations is also described in her patents.

Career Highlights

Celine Decaudin is currently associated with Sun Pharma Global Fze, where she continues to advance her research in drug formulations. Her work is pivotal in enhancing the efficacy of cancer treatments through innovative delivery systems.

Collaborations

Celine collaborates with Vincent Rogue, contributing to the development of groundbreaking formulations in the pharmaceutical industry.

Conclusion

Celine Decaudin's contributions to oncology drug formulations highlight her role as a leading inventor in the field. Her innovative approaches are set to make a significant impact on cancer treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…